Executive Summary
Estee Lauder Companies reported a resilient Q3 2024 with revenue of $3.94 billion, up 5.0% year over year and a gross margin of 71.9%, marking continued pricing power and favorable product mix within a premium beauty portfolio. Despite a sequential QoQ revenue decline of 7.92% and a modest reduction in operating momentum on a quarterly basis, the company delivered solid profitability with operating income of $531 million (operating margin of 13.5%) and net income of $330 million (net margin 8.38%), supported by meaningful operating leverage and cost discipline.
Cash generation remained robust, evidenced by $534 million in operating cash flow and $359 million in free cash flow for the quarter. The balance sheet shows substantial liquidity with $3.70 billion in cash and cash equivalents and total debt of $9.84 billion, resulting in a net debt position of approximately $6.14 billion. The company continued to fund capital returns and deleveraging initiatives, with $236 million in dividends paid and a modest debt repayment of $352 million during the period.
Valuation remains elevated relative to many consumer staples peers (P/E around 41x and P/S around 13.9x in the provided ratios). The portfolio strategy, brand equity, and higher-margin segments underpin long-term earnings resilience, but market anticipations around growth tempo, geographic mix, and currency effects warrant a measured stance. Investors should monitor topline trajectory in skincare and prestige makeup, expense discipline, working capital dynamics, and any shifts in consumer spend in higher-value channels as macro conditions evolve.
Key Performance Indicators
Key Insights
Revenue: USD 3.94B, YoY +5.04%, QoQ -7.92% (Q3 2024 vs Q3 2023 and Q2 2024)
Gross profit: USD 2.833B, YoY +9.30%, QoQ -9.34%
Operating income: USD 0.531B, YoY +78.79%, QoQ -7.49%
Net income: USD 0.330B, YoY +111.54%, QoQ +5.43%
EPS: USD 0.92, diluted 0.91, YoY +109.09%, QoQ +5.75%
Gross margin: 71.9%; Operating margin: 13.48%; Net margin: 8.38%
EBITDA: USD 0.759B; EBITDA margin: 19.26%
Cash flow from operations: USD 0.534B; Free cash flow: USD 0.359B
Cash at period end: USD 3.701B; Total debt: U...
Financial Highlights
Revenue: USD 3.94B, YoY +5.04%, QoQ -7.92% (Q3 2024 vs Q3 2023 and Q2 2024)
Gross profit: USD 2.833B, YoY +9.30%, QoQ -9.34%
Operating income: USD 0.531B, YoY +78.79%, QoQ -7.49%
Net income: USD 0.330B, YoY +111.54%, QoQ +5.43%
EPS: USD 0.92, diluted 0.91, YoY +109.09%, QoQ +5.75%
Gross margin: 71.9%; Operating margin: 13.48%; Net margin: 8.38%
EBITDA: USD 0.759B; EBITDA margin: 19.26%
Cash flow from operations: USD 0.534B; Free cash flow: USD 0.359B
Cash at period end: USD 3.701B; Total debt: USD 9.84B; Net debt: USD 6.139B
Current ratio: 1.576; Quick ratio: 1.150; Cash conversion cycle: 132.59 days
Dividends paid: USD 0.236B; Capital expenditures: USD 0.175B; Share repurchases: minimal (net in period)
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
3.94B |
5.04% |
-7.92% |
| Gross Profit |
2.83B |
9.30% |
-9.34% |
| Operating Income |
531.00M |
78.79% |
-7.49% |
| Net Income |
330.00M |
111.54% |
5.43% |
| EPS |
0.92 |
109.09% |
5.75% |
Key Financial Ratios
operatingProfitMargin
13.5%
operatingCashFlowPerShare
$1.49
dividendPayoutRatio
71.5%
Management Commentary
Transcript data not provided in the dataset; no earnings call excerpts available for extraction.
Forward Guidance
No explicit forward guidance is included in the provided data. Given the strong gross margin and solid free cash flow generation, a cautious expectation would be for continued profitability resilience and potential for higher shareholder returns if topline momentum stabilizes. Investors should monitor: (a) quarterly trends in skincare and prestige makeup segments, (b) mix and pricing power in premium channels, (c) currency headwinds/hedges affecting international revenue, (d) working capital dynamics given elevated days sales outstanding and inventory turnover signals, and (e) liquidity and capital allocation priorities (dividends vs. buybacks vs. debt reduction). Industry backdrop remains supportive for premium beauty in many regions, but valuation remains at the higher end of the consumer staples spectrum.